$PTCT 8-K SEC Filings

Filed On	Filing
21 Sep 2026	8-K: Regulation FD Disclosure; Other Events WARREN, N.J., Sept. 21, 2026 – PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it completed the previously announced agreement with Sangamo Therapeutics, Inc. to acquire ST-920 – a BLA-stage, one-time administered AAV gene th...
28 Aug 2026	8-K: Entry into a Material Definitive Agreement
13 Aug 2026	8-K: Regulation FD Disclosure; Other Events
30 Jul 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
18 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
16 Jun 2026	8-K: Other Events
09 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Apr 2026	8-K: Regulation FD Disclosure
25 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
19 Feb 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Feb 2026	8-K: Regulation FD Disclosure
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
29 Dec 2025	8-K: Entry into a Material Definitive Agreement
04 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
19 Aug 2025	8-K: Regulation FD Disclosure
07 Aug 2025	8-K: Entry into a Material Definitive Agreement
07 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Jul 2025	8-K: Regulation FD Disclosure

Comments